American Vanguard Corporation reported its financial results for the third quarter and the first nine months of 2025, revealing a modest increase in net sales but continued net losses. For the three months ended September 30, 2025, the company recorded net sales of $119.3 million, a 1% increase from $118.3 million in the same period of 2024. However, for the nine months ended September 30, 2025, net sales decreased by 5% to $364.4 million compared to $381.7 million in the prior year. The company’s gross profit for the third quarter surged to $34.2 million, up 98% from $17.3 million a year earlier, driven by a reduction in the cost of goods sold, which fell by 16% to $85.1 million.
Despite the increase in gross profit, American Vanguard reported a net loss of $12.4 million, or $(0.43) per share, for the third quarter of 2025, an improvement from a net loss of $25.7 million, or $(0.91) per share, in the same quarter of 2024. For the nine-month period, the net loss was $21.7 million, or $(0.76) per share, compared to a loss of $35.9 million, or $(1.28) per share, in the prior year. The company attributed the improved performance to lower operating expenses, which decreased by 11% in the third quarter, and a significant reduction in transformation costs.
Operationally, American Vanguard has undergone a transformation initiative that included restructuring its organization and integrating Canadian sales into its U.S. Crop business. This strategic shift is expected to enhance operational efficiency and improve financial performance. The company also faced challenges, including a 31% decline in sales of soil fumigant products due to a weak potato market and a 36% drop in its OHP business, which sells to ornamental and greenhouse markets, partly due to product liability claims. However, the herbicide segment saw an 82% increase, indicating strong demand in that area.
As of September 30, 2025, American Vanguard's total assets stood at $655 million, up from $636.7 million at the end of 2024. The company’s long-term debt increased to $182.3 million from $147.3 million, reflecting ongoing investments and operational adjustments. The company has not declared or paid dividends during the nine months ended September 30, 2025, as it focuses on maintaining liquidity and managing its financial obligations. Looking ahead, American Vanguard anticipates that ongoing efforts to streamline operations and manage costs will continue to support its recovery, although it remains cautious about market conditions and potential impacts on demand.
About AMERICAN VANGUARD CORP
American Vanguard Corporation (AVD) is a Delaware-based holding company specializing in agricultural solutions through its subsidiary, AMVAC Chemical Corporation. AVD develops and markets a range of chemical and biological products, including insecticides and herbicides, targeting agricultural, commercial, and consumer markets. With a focus on operational efficiency and digital transformation, AVD aims to enhance profitability and expand its global footprint while addressing environmental sustainability and regulatory challenges in the agrochemical industry.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.